10x Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	642.82	610.79	618.73	516.41	490.49
Revenue Growth (YoY)	5.24%	-1.28%	19.81%	5.28%	64.13%
Cost of Revenue	198.44	196.3	209.41	120.09	74.09
Gross Profit	444.38	414.48	409.31	396.32	416.4
Selling, General & Admin	310.13	343.24	343.33	295.8	257.56
Research & Development	234.53	264.7	265.73	264.27	211.75
Operating Expenses	544.67	607.94	609.06	560.07	469.31
Operating Income	-100.29	-193.46	-199.75	-163.74	-52.91
Interest Expense	-	-0	-0.03	-0.48	-0.87
Interest & Investment Income	20.05	18.93	16.89	6.65	0.21
Currency Exchange Gain (Loss)	2.5	-2.1	1.2	0.2	-0.9
Other Non Operating Income (Expenses)	-1.47	0.03	-1.49	-0.4	0.1
EBT Excluding Unusual Items	-79.21	-176.6	-183.18	-157.77	-54.38
Merger & Restructuring Charges	-10.6	-	-	-4.2	-
Asset Writedown	-	-1.1	-4.6	-	-
Legal Settlements	49.9	-	-	-	0.66
Pretax Income	-39.91	-177.7	-248.76	-161.97	-53.72
Income Tax Expense	3.64	4.93	6.34	4.03	4.51
Net Income	-43.54	-182.63	-255.1	-166	-58.22
Net Income to Common	-43.54	-182.63	-255.1	-166	-58.22
Shares Outstanding (Basic)	125	120	117	114	110
Shares Outstanding (Diluted)	125	120	117	114	110
Shares Change (YoY)	3.57%	2.80%	2.90%	3.18%	9.09%
EPS (Basic)	-0.35	-1.52	-2.18	-1.46	-0.53
EPS (Diluted)	-0.35	-1.52	-2.18	-1.46	-0.53
Free Cash Flow	130.12	-5.73	-63.8	-165.27	-122.65
Free Cash Flow Per Share	1.04	-0.05	-0.55	-1.45	-1.11
Gross Margin	69.13%	67.86%	66.15%	76.75%	84.89%
Operating Margin	-15.60%	-31.67%	-32.28%	-31.71%	-10.79%
Profit Margin	-6.77%	-29.90%	-41.23%	-32.15%	-11.87%
Free Cash Flow Margin	20.24%	-0.94%	-10.31%	-32.00%	-25.01%
EBITDA	-64.09	-157.58	-164.24	-138.38	-31.8
EBITDA Margin	-9.97%	-25.80%	-26.54%	-26.80%	-6.48%
D&A For EBITDA	36.2	35.88	35.51	25.37	21.12
EBIT	-100.29	-193.46	-199.75	-163.74	-52.91
EBIT Margin	-15.60%	-31.67%	-32.28%	-31.71%	-10.79%
Revenue as Reported	642.82	610.79	618.73	-	-
Advertising Expenses	2.5	3.9	3.3	3.7	4.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.